Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

152.89
+0.12000.08%
Post-market: 152.83-0.0600-0.04%19:33 EDT
Volume:4.46M
Turnover:691.88M
Market Cap:17.09B
PE:73.01
High:158.28
Open:153.49
Low:152.81
Close:152.77
52wk High:158.28
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:2.27
T/O Rate:4.37%
Dividend:0.28
Dividend Rate:0.18%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:2.36
PE(LYR):73.91

Loading ...

Revvity to Present at Wells Fargo Annual Healthcare Investor Conference

Reuters
·
Aug 11

Revvity Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 11

Revvity Releases Transcript of Q2 2026 Earnings Call

Reuters
·
Aug 06

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Revvity is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Aug 05

Revvity price target raised to $126 from $125 at Evercore ISI

TIPRANKS
·
Aug 05

Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating

MT Newswires Live
·
Aug 05

Revvity, Inc. : Bernstein Raises Target Price to $120 from $115

THOMSON REUTERS
·
Aug 05

Revvity, Inc. : JP Morgan Raises Target Price to $110 from $90

THOMSON REUTERS
·
Aug 05

Revvity Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 05

Stock Track | REVVITY INC Plummets 5.01% Intraday as Life Sciences Unit Weakness Overshadows Q2 Earnings Beat

Stock Track
·
Aug 04

Revvity Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Revvity Announces Q3 2026 Distribution of R$ 0.01 Per Unit, Payable Nov. 19

Reuters
·
Aug 04

Revvity Exec Says Co is Seeing Improving Demand from Biotech Customers, Aided by a Growing Number of AI-Related Orders - Conf Call

THOMSON REUTERS
·
Aug 04

Revvity Exec Says Decline in Life Sciences Unit was Driven by About 20% Decline in Co's Signal Software Business Due to Contract Timing

THOMSON REUTERS
·
Aug 04

Revvity Exec Says Co is NOW "More Optimistic" for Second Half of the Year Given the Diagnostic Trends

THOMSON REUTERS
·
Aug 04

Revvity Raises Annual Profit, Revenue Forecasts on Strong Diagnostics Demand

Reuters
·
Aug 04

Revvity Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2026 Outlook Raised

MT Newswires Live
·
Aug 04

GUIDANCE: (RVTY) Revvity Expects Full Year 2026 Revenue Range $2.83B-$2.86B, vs. FactSet Est of $2.83B

MT Newswires Live
·
Aug 04

GUIDANCE: (RVTY) Revvity Expects 2026 Adjusted EPS Range $5.30-$5.40, vs. FactSet Est of $5.24

MT Newswires Live
·
Aug 04